Letter: clarithromycin dose for H. pylori therapy remains unresolved – authors’ reply

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2036|42|5|632-633

ISSN： 0269-2813

Source： ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol.42, Iss.5, 2015-09, pp. : 632-633

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Letter: clarithromycin dose for H. pylori therapy remains unresolved

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 42, Iss. 5, 2015-09 ,pp. : 631-632

John Wiley & Sons Inc

Access to resources Recommend Favorite

Editorial: quadruple therapy for H. pylori eradication is better than triple therapy – authors' reply

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 7, 2015-04 ,pp. : 695-696

John Wiley & Sons Inc

Access to resources Recommend Favorite

Letter: effect of proton pump inhibitor use on invasive detection of Helicobacter pylori gastritis – authors' reply

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 6, 2015-03 ,pp. : 600-600

John Wiley & Sons Inc

Access to resources Recommend Favorite

Authors' reply to letter by C. Steffen

By  

EUROPEAN JOURNAL OF PAIN (ELECTRONIC), Vol. 19, Iss. 7, 2015-08 ,pp. : 1051-1053

John Wiley & Sons Inc

Access to resources Recommend Favorite

Letter: sitafloxacin for H. pylori infection in Japan: considerations on resistance rates, generalisability and its place in the therapeutic algorithm – author's reply

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 42, Iss. 7, 2015-10 ,pp. : 943-944

John Wiley & Sons Inc

Access to resources Recommend Favorite